Ibrahim John Malik

This inventor holds 18 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents, primarily in Antibody Therapeutics. Top assignee: H. Lundbeck A/s. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ibrahim John Malik. Retrieved from https://idiyas.com/inventor/ibrahim-john-malik

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 18 (Patent Applications = 2)

% Patents Active = 94.4

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 10.8

ph-index = 8

Forward Citations = 109(Granted Patents)

Company Filing History:

18 out of 513

H. Lundbeck A/s

patents

Years Active: 2019-2026

Loading Chart...

Areas of Expertise:

Anti-Sortilin Antibodies

Synucleinopathy

Therapeutic Agents

Antibody Treatment

Neurodegenerative Diseases

Biopharmaceuticals

Immunotherapy

Protein Engineering

Monoclonal Antibodies

Disease Modifiers

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12747294 - ANTI-SORTILIN ANTIBODIES AND USE THEREOF (2026-09-29),

2. 12331123 - Agent, uses and methods for treatment (2025-06-17),

3. 11548950 - Agent, uses and methods for treatment (2023-01-10),

4. 11542323 - Agents, uses and methods for the treatment of synucleinopathy (2023-01-03),

5. 11524995 - Agents, uses and methods for the treatment of synucleinopathy (2022-12-13),

6. 11421024 - Agents, uses and methods for the treatment of synucleinopathy (2022-08-23),

7. 10894833 - Agents, uses and methods for treatment (2021-01-19),

8. 10889650 - Agent, uses and methods for treatment (2021-01-12),

9. 10800836 - Agents, uses and methods for the treatment of synucleinopathy (2020-10-13),

10. 10647764 - Agents, uses and methods for the treatment of synucleinopathy (2020-05-12),

11. 10647763 - Agents, uses and methods for the treatment of synucleinopathy (2020-05-12),

12. 10640554 - Agents, uses and methods for the treatment of synucleinopathy (2020-05-05),

13. 10479835 - Agent, uses and methods for treatment (2019-11-19),

14. 10428147 - Anti-sortilin antibodies, uses and methods for treatment (2019-10-01),

15. 10364285 - Antibodies for the treatment of synucleinopathy (2019-07-30),

Title: Inventor Ibrahim John Malik

Introduction: Ibrahim John Malik is a prolific inventor based in Valby, Denmark, known for his groundbreaking contributions to various technological fields.

Latest Patents: Ibrahim John Malik holds several patents in the areas of renewable energy, sustainable transportation, and advanced materials.

Career Highlights: With a career spanning over two decades, Malik has worked with leading research institutions and universities to develop innovative solutions for global challenges.

Collaborations: Malik has collaborated with multinational companies and startups to bring his inventions to the market, showcasing his ability to bridge the gap between academia and industry.

Conclusion: Ibrahim John Malik's dedication to pushing the boundaries of innovation continues to inspire the next generation of inventors worldwide.

Profile summary based on public USPTO records.